Evidence map›Paper›PMID 28800101›Full record

ReviewCells2017

Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease.

Natalia Jiménez-Moreno, Petros Stathakos, Maeve A Caldwell, Jon D Lane

Abstract readReview
In one paragraph

Review in Cells, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalia Jiménez-MorenoCell Biology Laboratories, School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK. natalia.jimenezmoreno@bristol.ac.uk.
Petros StathakosCell Biology Laboratories, School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK. ps13590@bristol.ac.uk.
Maeve A CaldwellTrinity College Institute for Neuroscience, Trinity College, Dublin 2, Ireland. maeve.caldwell@tcd.ie.
Jon D LaneCell Biology Laboratories, School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK. jon.lane@bristol.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1Parkinson's UK H-1002Wellcome Trust
6 · The paper itself

Abstract

Human induced pluripotent stem cells (hiPSCs) are invaluable tools for research into the causes of diverse human diseases, and have enormous potential in the emerging field of regenerative medicine. Our ability to reprogramme patient cells to become hiPSCs, and to subsequently direct their differentiation towards those classes of neurons that are vulnerable to stress, is revealing how genetic mutations cause changes at the molecular level that drive the complex pathogeneses of human neurodegenerative diseases. Autophagy dysregulation is considered to be a major contributor in neural decline during the onset and progression of many human neurodegenerative diseases, meaning that a better understanding of the control of non-selective and selective autophagy pathways (including mitophagy) in disease-affected classes of neurons is needed. To achieve this, it is essential that the methodologies commonly used to study autophagy regulation under basal and stressed conditions in standard cell-line models are accurately applied when using hiPSC-derived neuronal cultures. Here, we discuss the roles and control of autophagy in human stem cells, and how autophagy contributes to neural differentiation in vitro. We also describe how autophagy-monitoring tools can be applied to hiPSC-derived neurons for the study of human neurodegenerative disease in vitro.

Indexed as

autophagic fluxautophagyhiPSCmitophagyneuronspluripotencystem cells

Identifiers

PMID28800101
PMCPMC5617970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.